Literature DB >> 17972951

Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD.

H-A Hou, W-C Chou, L-I Lin, C-Y Chen, J-L Tang, M-H Tseng, C-F Huang, R-J Chiou, F-Y Lee, M-C Liu, H-F Tien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17972951     DOI： 10.1038/sj.leu.2405005

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  22 in total

1.  Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.

Authors:  Rajyalakshmi Luthra; Keyur P Patel; Neelima G Reddy; Varan Haghshenas; Mark J Routbort; Michael A Harmon; Bedia A Barkoh; Rashmi Kanagal-Shamanna; Farhad Ravandi; Jorge E Cortes; Hagop M Kantarjian; L Jeffrey Medeiros; Rajesh R Singh
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

Review 2.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

3.  Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.

Authors:  C-H Tsai; H-A Hou; J-L Tang; C-Y Liu; C-C Lin; W-C Chou; M-H Tseng; Y-C Chiang; Y-Y Kuo; M-C Liu; C-W Liu; L-I Lin; W Tsay; M Yao; C-C Li; S-Y Huang; B-S Ko; S-C Hsu; C-Y Chen; C-T Lin; S-J Wu; H-F Tien
Journal:  Leukemia       Date:  2016-03-17       Impact factor: 11.528

4.  Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.

Authors:  Fei Yang; Tauangtham Anekpuritanang; Richard D Press
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

5.  Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.

Authors:  Sebastian Stasik; Jan-Niklas Eckardt; Michael Kramer; Christoph Röllig; Alwin Krämer; Sebastian Scholl; Andreas Hochhaus; Martina Crysandt; Tim H Brümmendorf; Ralph Naumann; Björn Steffen; Volker Kunzmann; Hermann Einsele; Markus Schaich; Andreas Burchert; Andreas Neubauer; Kerstin Schäfer-Eckart; Christoph Schliemann; Stefan Krause; Regina Herbst; Mathias Hänel; Norbert Frickhofen; Richard Noppeney; Ulrich Kaiser; Claudia D Baldus; Martin Kaufmann; Zdenek Rácil; Uwe Platzbecker; Wolfgang E Berdel; Jiri Mayer; Hubert Serve; Carsten Müller-Tidow; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Jan M Middeke; Christian Thiede
Journal:  Blood Adv       Date:  2021-09-14

6.  Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

Authors:  H A Hou; C C Lin; W C Chou; C Y Liu; C Y Chen; J L Tang; Y J Lai; M H Tseng; C F Huang; Y C Chiang; F Y Lee; Y Y Kuo; M C Lee; M C Liu; C W Liu; L I Lin; M Yao; S Y Huang; B S Ko; S C Hsu; S J Wu; W Tsay; Y C Chen; H F Tien
Journal:  Leukemia       Date:  2013-08-09       Impact factor: 11.528

7.  The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.

Authors:  Yuan-Yeh Kuo; Hsin-An Hou; Yin-Kai Chen; Li-Yu Li; Po-Hsuen Chen; Mei-Hsuan Tseng; Chi-Fei Huang; Fen-Yu Lee; Ming-Chih Liu; Chia-Wen Liu; Wen-Chien Chou; Chieh-Yu Liu; Jih-Luh Tang; Ming Yao; Hwei-Fang Tien
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

8.  Short loop functional commonality identified in leukaemia proteome highlights crucial protein sub-networks.

Authors:  Sun Sook Chung; Joseph C F Ng; Anna Laddach; N Shaun B Thomas; Franca Fraternali
Journal:  NAR Genom Bioinform       Date:  2021-03-01

9.  Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'.

Authors:  H-A Hou; L-I Lin; C-Y Chen; H-F Tien
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.

Authors:  Erica K Barnell; Kenneth F Newcomer; Zachary L Skidmore; Kilannin Krysiak; Sydney R Anderson; Lukas D Wartman; Stephen T Oh; John S Welch; Keith E Stockerl-Goldstein; Ravi Vij; Amanda F Cashen; Iskra Pusic; Peter Westervelt; Camille N Abboud; Armin Ghobadi; Geoffrey L Uy; Mark A Schroeder; John F Dipersio; Mary C Politi; David H Spencer; Eric J Duncavage; Timothy J Ley; Malachi Griffith; Meagan A Jacoby; Obi L Griffith
Journal:  JCO Precis Oncol       Date:  2021-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.